British Journal of Clinical Pharmacology · 1976 · 38 citations · 9 references
PharmacyPharmaceutical AnalysisPharmacologyCancer PharmacologyChemotherapyMass Spectrometric AnalysisChemotherapy Drug AdministrationDrug DispositionMetabolite ExtractionPharmacokinetics Of Anticancer Drugs5-Fluorouracil Therapy5-Fluorouracil TreatmentAssayAssay SensitivityGas Chromatography-mass SpectrometryInternal Standard AnalysisMass Spectrometric DetectionPlasma Components
1 A gas chromatographic-mass spectrometric method was developed for determining 5-fluorouracil in plasma, using methylated thymine as an internal standard. 2 5-fluorouracil was extracted from plasma by a novel procedure which removed plasma components interferring with the sensitivity of the assay. The method included heating the plasma, washing with ether and extracting the drug under optimum conditions. 3 The sensitivity of the assay was 10 ng/ml plasma, sufficient to determine the low concentrations of 5-fluorouracil found in plasma during continuous infusion of the drug in patients receiving chemotherapy for cancer.
9
5-Fluorouracil in Cancer: An Improved Regimen
John Horton · Annals of Internal Medicine · 1970 · 79 citations
Medicine, Oncology, Pharmacotherapy +17
Clinical pharmacology of oral and intravenous 5-fluorouracil (NSC-19893).
Cohen Jl, Irwin Le, Marshall Gj et al. · PubMed · 1975 · 72 citations